美国 · SEC FORM 4
TriSalus Life Sciences, Inc.
TLSI · Nasdaq · CIK 0001826667 · Healthcare · Medical Devices
内部人信号
5 位买方 · 6 条买入交易行 · $1.8M 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ 角色得分低 · 买入者中职位最高的是:CEO and President(CEO、董事长和持股 10% 以上的股东得分最低)
- ⚠ Purchase activity is becoming less recent
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: CEO and President, Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 78.4
- 78.4
- 78.4
- 78.3
- 78.2
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -13.6%
- 3M
- -4.0%
- 6M
- -3.8%
- 12M
- -16.3%
波动率与流动性
- 波动率
- 72.9%
- Beta
- —
- 平均每日成交额
- USD 1.1M
估值
- 市值
- USD 250.0M
- P/E
- —
基本面
- 利润率
- -86.9%
- ROE
- —
- 细分行业
- Medical Devices
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率 · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-04 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,346,635
- 上期报告
- 3,345,269
- 日均成交量
- 759,590
- 回补天数
- 4.4
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Wahlstrom Mats | 买入 (P) | Common Stock | 60,000 | USD 2.53 | USD 151,800 | SEC 申报 ↗ |
| 2026-05-15 | Szela Mary T | 买入 (P) | Common Stock | 39,682 | USD 2.59 | USD 102,776 | SEC 申报 ↗ |
| 2026-05-15 | Stansky Michael P | 买入 (P) | Common Stock | 610,000 | USD 2.50 | USD 1,525,000 | SEC 申报 ↗ |
| 2026-05-15 | Patience David | 买入 (P) | Common Stock | 7,100 | USD 2.43 | USD 17,253 | SEC 申报 ↗ |
| 2026-05-15 | Gordon Gary B. | 买入 (P) | Common Stock | 10,000 | USD 2.46 | USD 24,600 | SEC 申报 ↗ |
| 2026-02-23 | Valle William | 买入 (P) | Common Stock | 30,487 | USD 4.10 | USD 124,997 | SEC 申报 ↗ |
| 2026-02-23 | Szela Mary T | 买入 (P) | Common Stock | 30,487 | USD 4.10 | USD 124,997 | SEC 申报 ↗ |
| 2026-02-23 | Stansky Michael P | 买入 (P) | Common Stock | 361,098 | USD 4.10 | USD 1,480,502 | SEC 申报 ↗ |
| 2026-02-23 | Patience David | 买入 (P) | Common Stock | 3,657 | USD 4.10 | USD 14,994 | SEC 申报 ↗ |
| 2026-02-23 | Gordon Gary B. | 买入 (P) | Common Stock | 9,756 | USD 4.10 | USD 40,000 | SEC 申报 ↗ |
| 2025-02-05 | Young James Emmett | 买入 (P) | Common Stock | 6,000 | USD 5.65 | USD 33,900 | SEC 申报 ↗ |
| 2025-01-30 | Szela Mary T | 买入 (P) | Common Stock | 5,010 | USD 5.28 | USD 26,453 | SEC 申报 ↗ |
| 2025-01-29 | Szela Mary T | 买入 (P) | Common Stock | 5,030 | USD 5.03 | USD 25,301 | SEC 申报 ↗ |
| 2025-01-28 | Szela Mary T | 买入 (P) | Common Stock | 4,716 | USD 5.12 | USD 24,146 | SEC 申报 ↗ |
| 2025-01-28 | Murphy Sean | 买入 (P) | Common Stock | 15,000 | USD 5.17 | USD 77,550 | SEC 申报 ↗ |
Form 4 申报证据
55 transaction lines in the latest 365-day window; 129 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Szela Mary T | 代扣税 (F) | Common Stock | 2,693 | USD 4.38 | USD 11,795 | SEC 申报 ↗ |
| 2026-10-05 | Stevens Jennifer | 卖出 (S) | Common Stock | 316 | USD 4.39 | USD 1,387 | SEC 申报 ↗ |
| 2026-10-05 | Marshak Richard | 卖出 (S) | Common Stock | 325 | USD 4.39 | USD 1,427 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Szela Mary T | 代扣税 (F) | Common Stock | 2,693 | USD 4.38 | USD 11,795 | SEC 申报 ↗ |
| 2026-10-05 | Stevens Jennifer | 卖出 (S) | Common Stock | 316 | USD 4.39 | USD 1,387 | SEC 申报 ↗ |
| 2026-10-05 | Marshak Richard | 卖出 (S) | Common Stock | 325 | USD 4.39 | USD 1,427 | SEC 申报 ↗ |
| 2026-10-05 | Cox Bryan F. | 卖出 (S) | Common Stock | 296 | USD 4.39 | USD 1,299 | SEC 申报 ↗ |
| 2026-07-01 | Patience David | 代扣税 (F) | Common Stock | 14,650 | USD 4.46 | USD 65,339 | SEC 申报 ↗ |
| 2026-06-30 | Szela Mary T | 奖励/授予 (A) | Common Stock | 3,990 | USD 3.87 | USD 15,441 | SEC 申报 ↗ |
| 2026-06-30 | Marshak Richard | 奖励/授予 (A) | Common Stock | 561 | USD 3.87 | USD 2,171 | SEC 申报 ↗ |
| 2026-06-29 | Marshall Richard Henry | 奖励/授予 (A) | Common Stock | 60,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Marshak Richard | 卖出 (S) | Common Stock | 543 | USD 2.67 | USD 1,450 | SEC 申报 ↗ |
| 2026-05-15 | Wahlstrom Mats | 买入 (P) | Common Stock | 60,000 | USD 2.53 | USD 151,800 | SEC 申报 ↗ |
| 2026-05-15 | Szela Mary T | 买入 (P) | Common Stock | 39,682 | USD 2.59 | USD 102,776 | SEC 申报 ↗ |
| 2026-05-15 | Stansky Michael P | 买入 (P) | Common Stock | 610,000 | USD 2.50 | USD 1,525,000 | SEC 申报 ↗ |
| 2026-05-15 | Patience David | 买入 (P) | Common Stock | 7,100 | USD 2.43 | USD 17,253 | SEC 申报 ↗ |
| 2026-05-15 | Gordon Gary B. | 买入 (P) | Common Stock | 10,000 | USD 2.46 | USD 24,600 | SEC 申报 ↗ |
| 2026-05-14 | Wahlstrom Mats | 奖励/授予 (A) | Common Stock | 71,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Valle William | 奖励/授予 (A) | Common Stock | 52,754 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Stansky Michael P | 奖励/授予 (A) | Common Stock | 43,590 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | MATLIN DAVID J | 奖励/授予 (A) | Common Stock | 51,266 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | HICKS KERRY R | 奖励/授予 (A) | Common Stock | 28,201 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Gordon Gary B. | 奖励/授予 (A) | Common Stock | 52,754 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-17 | Szela Mary T | 卖出 (S) | Common Stock | 15,944 | USD 3.85 | USD 61,384 | SEC 申报 ↗ |
| 2026-03-16 | Stevens Jennifer | 卖出 (S) | Common Stock | 774 | USD 4.12 | USD 3,189 | SEC 申报 ↗ |
| 2026-03-16 | Marshak Richard | 卖出 (S) | Common Stock | 419 | USD 4.12 | USD 1,726 | SEC 申报 ↗ |
| 2026-03-16 | Devlin Jodi | 卖出 (S) | Common Stock | 273 | USD 4.12 | USD 1,125 | SEC 申报 ↗ |
| 2026-03-16 | Cox Bryan F. | 卖出 (S) | Common Stock | 579 | USD 4.12 | USD 2,385 | SEC 申报 ↗ |
| 2026-03-12 | Stevens Jennifer | 卖出 (S) | Common Stock | 1,552 | USD 4.09 | USD 6,348 | SEC 申报 ↗ |
| 2026-03-12 | Marshak Richard | 卖出 (S) | Common Stock | 1,589 | USD 4.09 | USD 6,499 | SEC 申报 ↗ |
| 2026-03-12 | Devlin Jodi | 卖出 (S) | Common Stock | 1,772 | USD 4.09 | USD 7,247 | SEC 申报 ↗ |
| 2026-03-12 | Cox Bryan F. | 卖出 (S) | Common Stock | 1,467 | USD 4.09 | USD 6,000 | SEC 申报 ↗ |
| 2026-03-11 | Szela Mary T | 卖出 (S) | Common Stock | 4,358 | USD 4.13 | USD 17,999 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | TLSI |
| CIK | 0001826667 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 129 transaction lines from 2023-06-12 to 2026-10-05 28 P purchase lines · 25 S sale lines · 76 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.